Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients

Table 5 The association of demographics and clinicopathologic characteristics with different scores

Variables	0 (n = 537)	1 (n = 219)	2 (n = 181)	3 (n = 139)	4 (n = 59)	5 (n = 71)	6 (n = 30)	P value
Gender								0.506
Male	413	158	136	104	50	55	21
Female	124	61	45	35	9	16	9
Age								0.179
< 65	316	124	98	68	31	36	12
≥ 65	221	95	83	71	28	35	18
Clinical stage								0.000
I	197	51	27	10	3	0	0
II	120	66	36	33	10	6	1
III	220	102	118	96	46	65	29
T stage								0.000
T1	147	48	15	10	3	0	1
T2	75	22	20	9	0	1	0
T3	56	37	27	25	13	13	3
T4	259	112	119	95	43	57	26
N stage								0.000
N0	292	96	64	36	11	4	1
N1	94	40	18	27	8	15	1
N2	73	37	44	32	14	17	10
N3	78	46	55	44	26	35	18
Tumor location								0.010
Cardia	268	95	97	77	37	41	18
Gastric body	93	58	28	26	11	14	9
Antrum of stomach	176	66	56	36	11	16	3
Pathological type								0.236
Adenocarcinoma	514	202	172	133	54	64	29
Other	23	17	9	6	5	7	1
Degree of differentiation								0.013
Well, high, medium	174	64	53	41	16	8	5
Moderate to low, poor	363	155	128	98	43	63	25
Borrmann type								0.000
I and II	241	80	42	48	10	15	6
III and IV	296	139	139	91	49	56	24
Size								0.000
< 5	364	121	91	66	17	22	9
≥ 5	173	98	90	73	42	49	21
Survival status
Alive	433	161	128	75	27	16	2
Dead	104	58	53	64	32	55	28